Showing results (1-10 of 305) with videos related to
Sort By:
Pageof 31
Endocrinology and Metabolism Clinics of North America|June 30, 2000
The immune response to the iodide transporterC Spitzweg, J C MorrisExperimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|September 27, 2001
Approaches to gene therapy with sodium/iodide symporterC Spitzweg, J C MorrisThyroid : Official Journal of the American Thyroid Association|September 11, 1999
Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cellsC Spitzweg, W Joba, J C Morris, et al.The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporterI V Scholz, N Cengic, B Göke, et al.The Journal of Urology|September 8, 2001
Gene therapy for prostate cancer: current status and future prospectsK J Harrington, C Spitzweg, A R Bateman, et al.The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
Analysis of human sodium iodide symporter immunoreactivity in human exocrine glandsC Spitzweg, W Joba, K Schriever, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 13, 2009
Gene therapy in thyroid cancerC SpitzwegThe Journal of Clinical Endocrinology and Metabolism|October 20, 2005
Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cellsS Unterholzner, M J Willhauck, N Cengic, et al.Der Internist|August 14, 2003
[The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance]C SpitzwegCancer Research|December 5, 2000
Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporterC Spitzweg, M K O'Connor, E R Bergert, et al.Pageof 31